Eccentricity effects on leakage of a brush seal at low speeds

The effects of eccentricity on brush seal leakage at low rotational speeds were investigated. Included are the leakage results for ambient temperature air and nearly saturated streams at three different rotor eccentricities at both 0 and 400 rpm. A brush seal with a nominal bore diameter of 13.647 cm. (5.3730 in.) was used. It had a radial concentric interference of 0.071 cm (0.0028 in.) and a fence height of 0.0927 cm (0.0365 in.). There were 1060 bristles per centimeter of circumference (2690 bristles per inch of circumference). Rotor eccentricities of 0.003, 0.010, 0.038, and 0.043 cm (0.001, 0.004, 0.015, and 0.017 in.) were achieved by using bushings with different offsets. The results were compared with an annular seal model (FLOWCAL) for air and to a standard labyrinth seal model for steam. The annular seal model was also compared with a bulk flow model of a concentric brush seal in air. Large eccentricities did not damage the brush seals or their Haynes 25 bristles. However, the 304 stainless steel rotor did not show wear, indicating a harder surface is needed. Only the stream data showed hysteresis and were affected by shaft rotation. The brush seal had lower leakage rates than those predicted for comparable annular and labyrinth seals (conventional) because of the large clearances those seals require to accommodate large shaft excursions

Some preliminary results of brush seal/rotor interference effects on leakage at zero and low RPM using a tapered-plug rotor

Some preliminary brush seal leakage results for ambient temperature air are presented. Data for four nominal brush rotor radial clearances of -0.09, -0.048, -0.008, and 0.035 mm were taken by using a tapered plug rotor at 0 and 400 rpm with rotor runout of 0.127 mm peak to peak. The brush seal nominal bore diameter was 38 mm with 0.05 mm bristles at 200 bristles/mm of circumference and a 0.61 mm fence height. Leakages were greater than predicted, but agreement was reasonable. Leakage rates were not significantly altered by hysteresis or inlet flow variations. Visualization studies showed that the bristles followed the 400 rpm excitation, and loading studies indicated that bristles slid relative to one another

Second primary malignancies in thyroid cancer patients

The late health effects associated with radioiodine ((131)I) given as treatment for thyroid cancer are difficult to assess since the number of thyroid cancer patients treated at each centre is limited. The risk of second primary malignancies (SPMs) was evaluated in a European cohort of thyroid cancer patients. A common database was obtained by pooling the 2-year survivors of the three major Swedish, Italian, and French cohorts of papillary and follicular thyroid cancer patients. A time-dependent analysis using external comparison was performed. The study concerned 6841 thyroid cancer patients, diagnosed during the period 1934-1995, at a mean age of 44 years. In all, 17% were treated with external radiotherapy and 62% received (131)I. In total, 576 patients were diagnosed with a SPM. Compared to the general population of each of the three countries, an overall significantly increased risk of SPM of 27% (95% CI: 15-40) was seen in the European cohort. An increased risk of both solid tumours and leukaemias was found with increasing cumulative activity of (131)I administered, with an excess absolute risk of 14.4 solid cancers and of 0.8 leukaemias per GBq of (131)I and 10(5) person-years of follow-up. A relationship was found between (131)I administration and occurrence of bone and soft tissue, colorectal, and salivary gland cancers. These results strongly highlight the necessity to delineate the indications of (131)I treatment in thyroid cancer patients in order to restrict its use to patients in whom clinical benefits are expected

The tyrosine kinase inhibitor sunitinib affects ovulation but not ovarian reserve in mouse: A preclinical study

The aim of the study was to evaluate ovarian toxicity of tyrosine kinase inhibitor (TKI) sunitinib, since only scarce data are available on gonadal function after this treatment. Six-weekold female mice received orally, once daily, vehicle or sunitinib (50 mg/kg/d) during 5 weeks. Fertility parameters were analyzed from ovulation to litter assessment. Sunitinib exposure significantly reduced (i) corpora lutea number per ovary (1.1 ± 0.38 in sunitinib group versus 4 ± 0.79 in control group, p<0.01) and (ii) serum Anti Müllerian hormone (AMH) levels in sunitinib treated mice (12.01 ± 1.16) compared to control mice (14.33 ± 0.87 ng/ml, p< 0.05). However, primordial and growing follicles numbers per ovary were not different in both groups. After treatment withdrawal, female mice in both groups were able to obtain litters. These data could be helpful to counsel clinicians and patients, when fertility preservation methods are discussed, before TKI treatment in girls and young women